EAACI Congress 2024

Back
31 May - 03 June 2024 Valencia, Spain

ENT 2

Saturday 01 Jun, 12:00 PM - 13:00 PM Valencia, Spain
Poster Zone Thematic Poster Session
12:00
Chacterisation of long-term nasal decongestant users and structured withdrawal of the nasal decongestant
12:00
Demographic Features Of Allergic Rhinitis Patients and Effect of Nasal Corticosteroid Treatment
12:00
Determinants of Adherence of Biologic Therapies in Chronic Rhinosinusitis
12:00
Diagnosis and Treatment of Allergies at ENT Department of General Hospital of Nafplio, Greece
12:00
Exhaled nitric oxide as a predictor of nasal polyp recurrence
12:00
Inotodiol attenuates mucosal inflammation in a mouse model of eosinophilic chronic rhinosinusitis
12:00
PERSISTENT REDUCTION OF TOTAL SERUM IgE IN CRSwNP AFTER ESS WITH SHORT COURSE DUPILUMAB
12:00
Role of non-pharmacological interventions in cypress pollen allergic rhinitis
12:00
The Role of Rho GTPase Signaling on Epithelial-Mesenchymal Transition and Inflammation of Chronic Rhinosinusitis with Nasal Polyp
12:00
The association between specific IgE levels and severity of allergic rhinitis, risk of allergic comorbidities
12:00
Use of nasal irrigation as add on therapy to non responders to pharmacotherapy in chronic adenoiditis

Chairs

Speakers